SCYNEXIS

SCYNEXIS Deferred Tax Liabilities

Deferred Tax Liabilities of SCYNEXIS (SCYX) as of Oct 19, 2026.

Deferred Tax Liabilities

-USD

Last updated:

Deferred Tax Liabilities of SCYNEXIS is 2026 - USD. Deferred Tax Liabilities of SCYNEXIS was 2025 - USD. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SCYNEXIS Stock analysis

What does SCYNEXIS do? SCYNEXIS Inc is a biopharmaceutical company that focuses on the discovery and development of novel therapeutics for serious infectious diseases and cancer. The company was founded in 2000 and is headquartered in New Jersey, USA. SCYNEXIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCYNEXIS stock

On Eulerpool you can find the complete historical development of Deferred Tax Liabilities SCYNEXIS since 2006 – with annual values, charts, and detailed analysis.

Deferred tax liabilities arise from temporary differences between accounting and tax treatments. They represent taxes owed in the future on income already recognized.

Deferred Tax Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Deferred Tax Liabilities's SCYNEXIS historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — SCYNEXIS

All Key Metrics — SCYNEXIS